Meet VBI Vaccines, The Biotech Up 100% In 2017
If you've been too distracted by the Snap Inc
SNAP
IPO lottery ticket trade to keep your eye on small-cap biotech moves, you may not have noticed VBI Vaccines, Inc. - shares quietly doubling in value since the start of the year.
VBI Vaccines is a biopharmaceutical focused on developing — you guessed it — vaccines, with an eye toward infectious disease and immuno-oncology.
VBI Vaccines is a biopharmaceutical focused on developing — you guessed it — vaccines, with an eye toward infectious disease and immuno-oncology.